Naples, FL – Stemtech Corporation (OTCQB:STEK), a global leader and pioneer in stem cell nutrition, is proud to appoint Dr. Lizette Leos, MD, to the role of Chief Scientific Officer.
President & COO, John W. Meyer stated:
“Dr. Leos has been with Stemtech since 2017 and has significantly contributed to the science, creation and development, including education of our stemceuticals™ all-natural, plant-based, non-GMO nutritional supplements designed to support the body’s own regenerative processes*.
“Promoting her to the role of Chief Scientific Officer recognizes both her longstanding impact and leadership in the development of new evidence-driven innovations. Her scientific knowledge of our products, ability to translate complex biology into practical education, and commitment to Stemtech’s non-chemical approaches to cellular health have been instrumental to Stemtech’s growth, with focus on anti-aging* and longevity. We are very excited about the future under her expanded scientific leadership.”
Mr. Meyer continued,
“As Chief Scientific Officer, Dr. Leos will lead Stemtech Corporation’s global scientific validation, education and regulatory alignment for Stemtech’s recently announced joint ventures in Stemtech HealthSciences India Pvt Ltd and the GCC (Gulf Cooperation Council countries of the United Arab Emirates, Bahrain, Saudi Arabia, Qatar, Kuwait and Oman). In addition, Dr. Leos will also support Stemtech Asia (Hong Kong) for